"Stomach Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the STOMACH.
| Descriptor ID |
D013274
|
| MeSH Number(s) |
C04.588.274.476.767 C06.301.371.767 C06.405.249.767 C06.405.748.789
|
| Concept/Terms |
Stomach Neoplasms- Stomach Neoplasms
- Neoplasm, Stomach
- Stomach Neoplasm
- Neoplasms, Stomach
- Gastric Neoplasms
- Gastric Neoplasm
- Neoplasm, Gastric
- Neoplasms, Gastric
Cancer of Stomach- Cancer of Stomach
- Stomach Cancers
- Gastric Cancer
- Cancer, Gastric
- Cancers, Gastric
- Gastric Cancers
- Stomach Cancer
- Cancer, Stomach
- Cancers, Stomach
- Cancer of the Stomach
|
Below are MeSH descriptors whose meaning is more general than "Stomach Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Stomach Neoplasms".
This graph shows the total number of publications written about "Stomach Neoplasms" by people in this website by year, and whether "Stomach Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 0 | 2 | 2 |
| 1997 | 3 | 0 | 3 |
| 1998 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 2 | 2 | 4 |
| 2003 | 3 | 0 | 3 |
| 2004 | 7 | 1 | 8 |
| 2005 | 2 | 1 | 3 |
| 2006 | 5 | 1 | 6 |
| 2007 | 3 | 0 | 3 |
| 2008 | 8 | 0 | 8 |
| 2009 | 2 | 1 | 3 |
| 2010 | 6 | 1 | 7 |
| 2011 | 8 | 1 | 9 |
| 2012 | 6 | 1 | 7 |
| 2013 | 8 | 0 | 8 |
| 2014 | 7 | 0 | 7 |
| 2015 | 6 | 0 | 6 |
| 2016 | 6 | 1 | 7 |
| 2017 | 11 | 1 | 12 |
| 2018 | 5 | 1 | 6 |
| 2019 | 8 | 2 | 10 |
| 2020 | 9 | 2 | 11 |
| 2021 | 5 | 0 | 5 |
| 2022 | 4 | 0 | 4 |
| 2023 | 6 | 0 | 6 |
| 2024 | 9 | 2 | 11 |
To return to the timeline,
click here.
Below are the most recent publications written about "Stomach Neoplasms" by people in Profiles.
-
Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw. 2024 12; 22(10):695-711.
-
Surgery enhances the effectiveness of peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumors. Surgery. 2025 Jan; 177:108834.
-
MEN1/DAXX/ATRX mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy. Endocr Relat Cancer. 2024 Nov 01; 31(11).
-
Quantitative SPECT/CT Metrics in Early Prediction of [177Lu]Lu-DOTATATE Treatment Response in Gastroenteropancreatic Neuroendocrine Tumor Patients. J Nucl Med. 2024 Oct 01; 65(10):1584-1590.
-
Germline CDH1 Variants and Lifetime Cancer Risk. JAMA. 2024 09 03; 332(9):722-729.
-
A multicenter, retrospective study of a through-the-needle injection-capable electrosurgical knife for endoscopic submucosal dissection. Gastrointest Endosc. 2024 Dec; 100(6):1034-1042.
-
Diabetes and gastric cancer incidence and mortality in the Asia Cohort Consortium: A pooled analysis of more than a half million participants. J Diabetes. 2024 Jun; 16(6):e13561.
-
Improving diagnostic accuracy of identifying gastric cancer patients with peritoneal metastases: tumor-guided cell-free DNA analysis of peritoneal fluid. Oncogene. 2024 Jun; 43(24):1877-1882.
-
Family history and gastric cancer incidence and mortality in Asia: a pooled analysis of more than half a million participants. Gastric Cancer. 2024 Jul; 27(4):701-713.
-
Somatic mouse models of gastric cancer reveal genotype-specific features of metastatic disease. Nat Cancer. 2024 Feb; 5(2):315-329.